Evidence map›Paper›PMID 24639499›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Modulation of synaptic function through the α-neurexin-specific ligand neurexophilin-1.

Gesche Born, Dorothee Breuer, Shaopeng Wang, Astrid Rohlmann, Philippe Coulon, Puja Vakili, Carsten Reissner, Friedemann Kiefer, Martin Heine, Hans-Christian Pape and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. GABAMedComm · 2025
    Review
  9. Article
  10. Article
  11. Alpha-neurexins in health and disease.Frontiers in molecular neuroscience · 2025
    Review
  12. Article
  13. NXPH4 mediated by mCellular & molecular biology letters · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Gesche BornInstitute of Anatomy and Molecular Neurobiology, Westfälische Wilhelms-University, D-48149 Münster, Germany.
Dorothee Breuer
Shaopeng Wang
Astrid Rohlmann
Philippe Coulon
Puja Vakili
Carsten Reissner
Friedemann Kiefer
Martin Heine
Hans-Christian Pape
Markus Missler
University of Münster · DELeibniz Institute for Neurobiology · DEMax Planck Institute for Molecular Biomedicine · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurotransmission at different synapses is highly variable, and cell-adhesion molecules like α-neurexins (α-Nrxn) and their extracellular binding partners determine synapse function. Although α-Nrxn affect transmission at excitatory and inhibitory synapses, the contribution of neurexophilin-1 (Nxph1), an α-Nrxn ligand with restricted expression in subpopulations of inhibitory neurons, is unclear. To reveal its role, we investigated mice that either lack or overexpress Nxph1. We found that genetic deletion of Nxph1 impaired GABAB receptor (GABA(B)R)-dependent short-term depression of inhibitory synapses in the nucleus reticularis thalami, a region where Nxph1 is normally expressed at high levels. To test the conclusion that Nxph1 supports presynaptic GABA(B)R, we expressed Nxph1 ectopically at excitatory terminals in the neocortex, which normally do not contain this molecule but can be modulated by GABA(B)R. We generated Nxph1-GFP transgenic mice under control of the Thy1.2 promoter and observed a reduced short-term facilitation at these excitatory synapses, representing an inverse phenotype to the knockout. Consistently, the diminished facilitation could be reversed by pharmacologically blocking GABA(B)R with CGP-55845. Moreover, a complete rescue was achieved by additional blocking of postsynaptic GABA(A)R with intracellular picrotoxin or gabazine, suggesting that Nxph1 is able to recruit or stabilize both presynaptic GABA(B)R and postsynaptic GABA(A)R. In support, immunoelectron microscopy validated the localization of ectopic Nxph1 at the synaptic cleft of excitatory synapses in transgenic mice and revealed an enrichment of GABA(A)R and GABA(B)R subunits compared with wild-type animals. Thus, our data propose that Nxph1 plays an instructive role in synaptic short-term plasticity and the configuration with GABA receptors.

Indexed as

AnimalsExcitatory Postsynaptic PotentialsGABAergic NeuronsGlycoproteinsInterneuronsLigandsMiceMice, KnockoutMice, TransgenicNerve Tissue ProteinsNeuropeptidesProtein SubunitsReceptors, GABA-AReceptors, GABA-BSubstrate SpecificitySynapsesGlycoproteinsLigandsNerve Tissue ProteinsneurexophilinNeuropeptidesProtein SubunitsReceptors, GABA-AReceptors, GABA-Bautismneuroliginsynaptic transmissionthalamusultrastructure

Identifiers

PMID24639499
PMCPMC3977266
OpenAlexW2030609432

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.